Medical expertise company RubiconMD on Thursday announced a suite of COVID-19 vaccine eConsults and resources to continue to support the primary care physicians deliver the clear, accurate communication vital in the fight against the pandemic.
RubiconMD's panel of COVID-19 vaccine experts will review the real eConsult case studies and leverage educational resources curated in partnership with CONVINCE USA Initiative at the CUNY Graduate School of Public Health and Health Policy.
Based on the survey of RubiconMD clinicians, about 50% of respondents felt that they do not have all the resources needed to make vaccine decisions to adequately address patient questions. Respondents strongly emphasized the need for digestible summaries of vaccine recommendations, clinical guidelines for patients with complex conditions, and multilingual patient-facing resources.
Following the feedback, RubiconMD encourages clinicians to reach out to their specialist experts with any vaccine questions and leverage the dashboard for continually updated curated content and CME eligible webinars.
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio
GSK and IQVIA expand vaccine track with local data to drive targeted public health action
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137